Ameriprise’s Livongo Health, Inc. Common Stock LVGO Stock Holding History

Ameriprise’s Portfolio LVGO Stock Details LVGO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-357,440	Closed	-$50.1M	–	3891
2020 Q3	$50.1M	Sell	357,440 -457,363	-56%	-$55.7M	0.02%	642
2020 Q2	$61.3M	Sell	814,803 -772,104	-49%	-$40.4M	0.03%	545
2020 Q1	$45.3M	Buy	1,586,907 +628,715	+66%	+$16.3M	0.02%	584
2019 Q4	$24M	Buy	+958,192	New	+$22.9M	0.01%	1050

Ameriprise's LVGO Position: Q4 2020 in Review

Ameriprise sold out of Livongo Health, Inc. Common Stock (LVGO) in Q4 2020, closing a stake of 357,440 shares — an estimated $50.1M sold.

Ameriprise first reported a position in LVGO in Q4 2019 and held it in 4 quarters. The position peaked at $61.3M in Q2 2020. 0 funds tracked by Wall St. Rank hold LVGO as of Q4 2020.

Ameriprise reported no remaining Livongo Health, Inc. Common Stock position as of Q4 2020 after selling out during the quarter.
Ameriprise sold 357,440 Livongo Health, Inc. Common Stock shares in Q4 2020, an estimated $50.1M.
Ameriprise first reported a position in Livongo Health, Inc. Common Stock in Q4 2019 and held it in 4 quarters.
Ameriprise's Livongo Health, Inc. Common Stock position peaked at $61.3M in Q2 2020.
0 funds tracked by Wall St. Rank held Livongo Health, Inc. Common Stock as of Q4 2020.

Based on Ameriprise's 13F filing for Q4 2020, filed 12 Feb 2021.